Antizol Related Published Studies
Well-designed clinical trials related to Antizol (Fomepizole)
Fomepizole as an antidote for ethylene glycol poisoning. [2002.06]
Well-designed clinical trials possibly related to Antizol (Fomepizole)
Evaluation of 4-methylpyrazole as a potential therapeutic dark adaptation inhibitor. [2007.10]
Increased plasma fatty acid ethyl ester levels following inhibition of oxidative metabolism of ethanol by 4-methylpyrazole treatment in human subjects. [2006.07]
Testosterone increases in men after a low dose of alcohol. [2003.04]
Ethanol, acetaldehyde, acetate, and lactate levels after alcohol intake in white men and women: effect of 4-methylpyrazole. [2002.02]
Effect of 4-methylpyrazole on endogenous plasma ethanol and methanol levels in humans. [2001.04]
Kinetic interactions between 4-methylpyrazole and ethanol in healthy humans. [1996.08]
Comparison of ethanol and 4-methylpyrazole as treatments for ethylene glycol intoxication in cats. [1994.12]
Non-linear kinetics of 4-methylpyrazole in healthy human subjects. [1989]
4-Methylpyrazole and the cutaneous vascular sensitivity to alcohol in Orientals. [1988.08]
4-Methylpyrazole: a controlled study of safety in healthy human subjects after single, ascending doses. [1988.08]
Other research related to Antizol (Fomepizole)
Medication errors associated with the use of ethanol and fomepizole as antidotes for methanol and ethylene glycol poisoning. [2011.06]
Effect of lycopene on caspase-3 enzyme activation in liver of methanol-intoxicated rats: comparison with fomepizole. [2010.08]
Fomepizole fails to prevent progression of acidosis in 2-butoxyethanol and ethanol coingestion. [2010.07]
Fomepizole for the treatment of pediatric ethylene and diethylene glycol, butoxyethanol, and methanol poisonings. [2010.06]
Protective effects of fomepizole on 2-chloroethanol toxicity. [2010.06]
Massive ethylene glycol ingestion treated with fomepizole alone-a viable therapeutic option. [2010.06]
Safety and efficacy of high-dose fomepizole compared with ethanol as therapy for ethylene glycol intoxication in cats. [2010.04.01]
Adverse drug events associated with the antidotes for methanol and ethylene glycol poisoning: a comparison of ethanol and fomepizole. [2009.04]
Fomepizole: a critical assessment of current dosing recommendations. [2009.02]
Bradycardia and hypotension associated with fomepizole infusion during hemodialysis. [2008.07]
Expert opinion: fomepizole may ameliorate the need for hemodialysis in methanol poisoning. [2008.07]
Oral administration of fomepizole produces similar blood levels as identical intravenous dose. [2008.03]
The management of severe toxic alcohol ingestions at a tertiary care center after the introduction of fomepizole. [2007.09]
Ethylene glycol ingestion treated only with fomepizole. [2007.09]
Compliance with poison center fomepizole recommendations is suboptimal in cases of toxic alcohol poisoning. [2006.11]
Fomepizole may change indication for hemodialysis in methanol poisoning: prospective study in seven cases. [2005.09]
Fomepizole as a therapeutic strategy in paediatric methanol poisoning. A case report and review of the literature. [2005.03]
Methanol and formate kinetics during treatment with fomepizole. [2005]
Fomepizole alone for severe infant ethylene glycol poisoning. [2004.09]
Inhalational methanol toxicity in pregnancy treated twice with fomepizole. [2003.02]
Antidote review: fomepizole for methanol poisoning. [2003.01]
Fomepizole therapy for reversal of visual impairment after methanol poisoning: a case documented by visual evoked potentials investigation. [2002.12]
[Severe ethylene glycol poisoning treated wtih fomepizole (4-methylpyrazole)] [2002.10.20]
Role of fomepizole in the management of ethylene glycol toxicity. [2002.03]
Treatment of a 1,4-butanediol poisoning with fomepizole. [2002]
Childhood methanol ingestion treated with fomepizole and hemodialysis. [2001.10]
Treatment of acute methanol poisoning with fomepizole. [2001.08]
Fomepizole for the treatment of methanol poisoning. [2001.02.08]
Reversal of severe methanol-induced visual impairment: no evidence of retinal toxicity due to fomepizole. [2001]
Treatment of methanol and isopropanol poisoning with intravenous fomepizole. [2001]
Fomepizole treatment of ethylene glycol poisoning in an infant. [2000.12]
Toxicokinetics of ethylene glycol during fomepizole therapy: implications for management. For the Methylpyrazole for Toxic Alcohols Study Group. [2000.08]
Childhood diethylene glycol poisoning treated with alcohol dehydrogenase inhibitor fomepizole and hemodialysis. [2000.05]
Nystagmus secondary to fomepizole administration in a pediatric patient. [2000]
Fomepizole for the treatment of ethylene glycol poisoning. Methylpyrazole for Toxic Alcohols Study Group. [1999.03.18]
Fomepizole (4-methylpyrazole) in fatal methanol poisoning with early CT scan cerebral lesions. [1999]
Other possibly related research studies
[Acute methanol intoxication: physiopathology, prognosis and treatment] [2006]
Update on antidotes for pediatric poisoning. [2006.11]
New and novel antidotes in pediatrics. [2006.07]
Prehospital diagnosis of massive ethylene glycol poisoning and use of an early antidote. [2006.08]
Hyperosmolality: another indication for hemodialysis following acute ethylene glycol poisoning. [2006]
The total antioxidant status in the brain after ethanol or 4-methylpyrazole administration to rats intoxicated with methanol. [2006.07]
Resuscitative treatments on 1,4-butanediol mortality in mice. [2006.02]
Methanol outbreak in Norway 2002-2004: epidemiology, clinical features and prognostic signs. [2005.08]
Current recommendations for treatment of severe toxic alcohol poisonings. [2005.02]
Outcomes following abuse of methanol-containing carburetor cleaners. [2004.10]
Aniline and methanol toxicity after shoe dye ingestion. [2004.11]
Ethylene glycol toxicity. [2004.08]
Treatment of severe pediatric ethylene glycol intoxication without hemodialysis. [2004]
Plasma and tissue determination of 4-methylpyrazole for pharmacokinetic analysis in acute adult and pediatric methanol/ethylene glycol poisoning. [2004.06]
Ethylene glycol intoxication: case report and pharmacokinetic perspectives. [2003.12]
Rethinking the toxic methanol level. [2003]
Methanol ingestion: prevention of toxic sequelae after massive ingestion. [2003.05]
Cinnamic compound metabolism in human skin and the role metabolism may play in determining relative sensitisation potency. [2003.02]
Treatment of ethylene glycol poisoning. [2002.09.01]
Mechanism of superoxide anion production by hepatic sinusoidal endothelial cells and Kupffer cells during short-term ethanol perfusion in the rat. [2002.08]
American Academy of Clinical Toxicology practice guidelines on the treatment of methanol poisoning. [2002]
Suppression of the contact hypersensitivity response following topical exposure to 2-butoxyethanol in female BALB/c mice. [2002.03]
Comparison of the therapeutic efficacy of 4-methylpyrazole and N-acetylcysteine on acetaminophen (paracetamol) hepatotoxicity in rats. [2002]
Concurrent administration of diethyldithiocarbamate and 4-methylpyrazole enhances ethanol-induced locomotor activity: the role of brain ALDH. [2002.04]
Current management of ethylene glycol poisoning. [2001]
4-Methylpyrazole decreases salivary acetaldehyde levels in aldh2-deficient subjects but not in subjects with normal aldh2. [2001.06]
Severe ethylene glycol ingestion treated without hemodialysis. [2001.01]
Diagnosis and treatment of an unusual cause of metabolic acidosis: ethylene glycol poisoning. [1999.12]
Constitutive and inducible expression of hepatic CYP2E1 in leptin-deficient ob/ob mice. [2000.02.16]
Survey of the stocking of poison antidotes in Alabama hospitals. [1999.12]
Two cases of acute methanol poisoning partially treated by oral 4-methylpyrazole. [1999.05]
Novel therapies for ethylene glycol intoxication. [1999.06]
Glycolate kinetics and hemodialysis clearance in ethylene glycol poisoning. META Study Group. [1998]
Acute and chronic ethanol increases reactive oxygen species generation and decreases viability in fresh, isolated rat hepatocytes. [1998.11]
Mechanisms of inactivation of hepatocyte protein kinase C isoforms following acute ethanol treatment. [1998.09]
Ethylene glycol poisoning in a child treated with 4-methylpyrazole. [1998.09]
Ethylene glycol poisoning treated by intravenous 4-methylpyrazole. [1998.07]
Gastroprotection by 4-methylpyrazole against ethanol in humans. [1998.04]
Treatment of methanol poisoning with intravenous 4-methylpyrazole. [1997.12]
Ethylene glycol poisoning: case report of a record-high level and a review. [1997.09]
High-performance liquid chromatographic determination of 4-methylpyrazole in plasma and in dialysate. [1997.08.01]
Oxidative stress-mediated apoptosis of hepatocytes exposed to acute ethanol intoxication. [1997.02]
Intravenous 4-methylpyrazole as an antidote for diethylene glycol and triethylene glycol poisoning: a case report. [1997.02]
Safety and efficacy of 4-methylpyrazole for treatment of suspected or confirmed ethylene glycol intoxication in dogs: 107 cases (1983-1995). [1996.12.01]
Effect of acetaldehyde generated from ethanol by ADH-transfected CHO cells on their membrane fatty acid profiles. [1996.11]
4-Methylpyrazole and hemodialysis in ethylene glycol poisoning. [1996]
4-methylpyrazole monitoring during haemodialysis of ethylene glycol intoxicated patients. [1995]
4-Methylpyrazole blocks acetaminophen hepatotoxicity in the rat. [1994.03]
An in vitro model of ethanol-dependent liver cell injury. [1994.01]
Efficacy of 4-methylpyrazole in ethylene glycol poisoning: clinical and toxicokinetic aspects. [1994.01]
Effects of ethanol on urinary acidification and on gluconeogenesis by isolated renal tubules. [1993.10]
Acute ethanol intoxication stimulates superoxide anion production by in situ perfused rat liver. [1992.05]
[Do antidotes have a future? The example of 4-methylpyrazole and hydroxocobalamin] [1992.02]
NADPH-dependent reduction of amaranch in liver microsomes characterized the quantity of low spin forms of cytochrome P-450. [1991.09.16]
|
